Form 4: Jonathan Lim Reports Conversion of Preferred Stock to Common Stock in Boundless Bio, Inc.

Director Jonathan Lim reports the conversion of preferred stock to common stock in Boundless Bio, Inc. following the company's initial public offering.

Summary

• On April 2, 2024, Jonathan Lim, a director of Boundless Bio, Inc., reported the conversion of preferred stock into common stock.
• The conversion occurred following the closing of Boundless Bio's initial public offering (IPO).
• A total of 525,274 shares of preferred stock were converted into common stock.
• After the transaction, Lim directly owns 102,564 shares of common stock and indirectly owns 550,915 shares through City Hill, LLC.
• Lim disclaims beneficial ownership of the shares held by City Hill, LLC, except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing related to the conversion of preferred stock to common stock following an IPO. It doesn't contain any particularly positive or negative information, but the completion of the IPO is generally a positive event.

Industry Context

Form 4 filings are standard practice for company insiders (directors, officers, and principal stockholders) to report transactions in their company's stock, providing transparency to the market.

Key Dates